Emergent BioSolutions Inc. (EBS)
NYSE: EBS · IEX Real-Time Price · USD
6.48
+0.09 (1.41%)
At close: Jun 11, 2024, 4:00 PM
6.54
+0.06 (0.93%)
After-hours: Jun 11, 2024, 7:59 PM EDT
Emergent BioSolutions Market Cap
Emergent BioSolutions has a market cap or net worth of $339.56 million as of June 11, 2024. Its market cap has decreased by -14.90% in one year.
Market Cap
339.56M
Enterprise Value
1.17B
1-Year Change
-14.90%
Ranking
Category
Stock Price
$6.48
Market Cap Chart
Since November 15, 2006, Emergent BioSolutions's market cap has increased from $320.80M to $339.56M, an increase of 5.85%. That is a compound annual growth rate of 0.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2024 | 339.60M | 1.43% |
| Jun 10, 2024 | 334.80M | 3.21% |
| Jun 7, 2024 | 324.40M | -1.10% |
| Jun 6, 2024 | 328.00M | -6.15% |
| Jun 5, 2024 | 349.50M | 19.94% |
| Jun 4, 2024 | 291.40M | -8.99% |
| Jun 3, 2024 | 320.20M | 7.20% |
| May 31, 2024 | 298.70M | 12.00% |
| May 30, 2024 | 266.70M | 9.71% |
| May 29, 2024 | 243.10M | -1.70% |
| May 28, 2024 | 247.30M | -0.84% |
| May 24, 2024 | 249.40M | -3.67% |
| May 23, 2024 | 258.90M | -1.60% |
| May 22, 2024 | 263.10M | -3.06% |
| May 21, 2024 | 271.40M | -10.69% |
| May 20, 2024 | 303.90M | 4.50% |
| May 17, 2024 | 290.80M | 5.29% |
| May 16, 2024 | 276.20M | -7.69% |
| May 15, 2024 | 299.20M | 12.40% |
| May 14, 2024 | 266.20M | -5.23% |
| May 13, 2024 | 280.90M | 23.26% |
| May 10, 2024 | 227.90M | -0.48% |
| May 9, 2024 | 229.00M | -0.91% |
| May 8, 2024 | 231.10M | 0.22% |
| May 7, 2024 | 230.60M | 10.55% |
View and export this data all the way back to 2006.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nevro | 349.29M |
| enGene Holdings | 348.84M |
| Vanda Pharmaceuticals | 348.03M |
| Xeris Biopharma Holdings | 343.95M |
| OraSure Technologies | 340.95M |
| Alto Neuroscience | 334.44M |
| Sonida Senior Living | 333.06M |
| C4 Therapeutics | 331.64M |